Cargando…

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome

Bleeding events in patients with acute coronary syndrome (ACS) are a risk factor for adverse outcomes, including mortality. We investigated the association of growth differentiation factor (GDF)-15, an established predictor of bleeding complications, with on-treatment platelet reactivity in ACS pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mutschlechner, David, Tscharre, Maximilian, Wadowski, Patricia P., Pultar, Joseph, Weikert, Constantin, Lee, Silvia, Eichelberger, Beate, Panzer, Simon, Perkmann, Thomas, Gremmel, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966081/ https://www.ncbi.nlm.nih.gov/pubmed/36836162 http://dx.doi.org/10.3390/jcm12041627

Ejemplares similares

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
por: Tscharre, Maximilian, et al.
Publicado: (2020)

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices
por: Tscharre, Maximilian, et al.
Publicado: (2022)

Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes
por: Wadowski, Patricia P., et al.
Publicado: (2020)

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y(12) inhibitors
por: Wadowski, Patricia P., et al.
Publicado: (2019)

Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors
por: Wadowski, Patricia P., et al.
Publicado: (2020)

Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia
por: Lee, Silvia, et al.
Publicado: (2020)

Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy
por: Wadowski, Patricia P., et al.
Publicado: (2017)

Interleukin-6 and Asymmetric Dimethylarginine Are Associated with Platelet Activation after Percutaneous Angioplasty with Stent Implantation
por: Gremmel, Thomas, et al.
Publicado: (2015)

Protease‐activated receptor‐mediated platelet aggregation in patients with type 2 diabetes on potent P2Y (12) inhibitors
por: Panzer, Benjamin, et al.
Publicado: (2022)

Platelet-to-lymphocyte and Neutrophil-to-lymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent Implantation
por: Lee, Silvia, et al.
Publicado: (2020)

Plasma Levels of snoRNAs are Associated with Platelet Activation in Patients with Peripheral Artery Disease
por: Nossent, Anne Yaël, et al.
Publicado: (2019)

Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy
por: Gremmel, Thomas, et al.
Publicado: (2015)

Functional capillary impairment in patients with ventricular assist devices
por: Wadowski, Patricia P., et al.
Publicado: (2019)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
por: Stojkovic, Stefan, et al.
Publicado: (2020)

Microvascular Thrombosis as a Critical Factor in Severe COVID-19
por: Wadowski, Patricia P., et al.
Publicado: (2023)

Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review
por: Panzer, Benjamin, et al.
Publicado: (2023)

Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting
por: Lee, Silvia, et al.
Publicado: (2018)

Glycocalyx as Possible Limiting Factor in COVID-19
por: Wadowski, Patricia P., et al.
Publicado: (2021)

Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting
por: Demyanets, Svitlana, et al.
Publicado: (2020)

The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome
por: Pogran, Edita, et al.
Publicado: (2023)

Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease—Pathophysiology and Translational Therapeutic Approaches
por: Poledniczek, Michael, et al.
Publicado: (2023)

Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis
por: Wang, Jinghan, et al.
Publicado: (2020)

Acute Limb Ischemia after Intake of the Phenylethylamine Derivate NBOMe
por: Wadowski, Patricia P., et al.
Publicado: (2019)

Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA): A cluster-randomized trial
por: Rohla, Miklos, et al.
Publicado: (2018)

Tunable activation of therapeutic platelet-rich plasma by pulse electric field: Differential effects on clot formation, growth factor release, and platelet morphology
por: Frelinger, Andrew L., et al.
Publicado: (2018)

Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
por: Jäger, Bernhard, et al.
Publicado: (2018)

Assay validity of point-of-care platelet function tests in thrombocytopenic blood samples
por: Lacom, Conrad, et al.
Publicado: (2022)

Platelet reactivity expressed as a novel platelet reactivity score is associated with higher inflammatory state after coronary artery bypass grafting
por: Wilczyński, Mirosław, et al.
Publicado: (2019)

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Tscharre, Maximilian, et al.
Publicado: (2022)

Platelet Reactivity and Outcomes after Off-Pump Coronary Surgery in Acute Coronary Syndrome Patients
por: Soh, Sarah, et al.
Publicado: (2022)

Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry
por: Tscharre, Maximilian, et al.
Publicado: (2017)

Three Cases of Tickborne Francisella tularensis Infection, Austria, 2022
por: Heger, Florian, et al.
Publicado: (2023)

A Sex-Specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention
por: Leutner, Michael, et al.
Publicado: (2019)

The Relationship between Fractional Flow Reserve, Platelet Reactivity and Platelet Leukocyte Complexes in Stable Coronary Artery Disease
por: Sels, Jan-Willem E. M., et al.
Publicado: (2013)

Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2019)

Predictors of high on-aspirin platelet reactivity in elderly patients with coronary artery disease
por: Zhang, JW, et al.
Publicado: (2017)

Platelet Reactivity Was Not Associated with Infarct Size after Primary Percutaneous Coronary Intervention
por: Park, Seohwa, et al.
Publicado: (2021)

High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions
por: Urban, Lukáš, et al.
Publicado: (2023)

Flavanols and Platelet Reactivity
por: Pearson, Debra A., et al.
Publicado: (2005)

High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention
por: Zhang, Jun-Jie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ihiudtk13l2s3vce13bspif60q